# China NMPA Drug Inspection - Jilin Yinnuoke Pharmaceutical Co., Ltd. - Jing Shi Ling Capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/jilin-yinnuoke-pharmaceutical-co-ltd/e8f86143-ea62-4320-aa80-265e38bd16cb/
Source feed: China

> China NMPA drug inspection for Jilin Yinnuoke Pharmaceutical Co., Ltd. published March 25, 2020. Drug: Jing Shi Ling Capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 1, 2020)
- Company Name: Jilin Yinnuoke Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-25
- Drug Name: Jing Shi Ling Capsules
- Inspection Finding: [Properties], [Test] Moisture content
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/jilin-yinnuoke-pharmaceutical-co-ltd/a4f56b84-e4ce-46e2-95c4-4025a26adbf6/